The National Institute on Drug Abuse (NIDA) is offering this grant to investigate the effects of anti-retroviral therapy (ART) on neuronal and glial structure and function in individuals with HIV. This grant is for the purpose of understanding how ART, particularly when occurring in a background of chronic exposure to abused drugs like opioids, cocaine, stimulants, cannabinoids, and nicotine, contributes to neurological and neurocognitive deficits. The overall goal is to determine the contributions of ARV treatment regimens to HIV-Associated Neurocognitive Disorders (HAND) and to elucidate the mechanisms behind these impairments.
Opportunity ID: 334305
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-003 |
| Funding Opportunity Title: | Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 – Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 23, 2021 |
| Last Updated Date: | Jun 23, 2021 |
| Original Closing Date for Applications: | Feb 02, 2022 |
| Current Closing Date for Applications: | Feb 02, 2022 |
| Archive Date: | Mar 10, 2022 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments City or township governments Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Institute on Drug Abuse [NIDA] seeks research proposals to identify the effects of anti-retroviral therapy (ART) used for the treatment of HIV/AIDS on neuronal and glial structure and function, particularly when occurring in a background of chronic exposure to an abused drug (including opioids, cocaine and stimulants, cannabinoids, and nicotine). The overall goal is to determine the contributions of antiretroviral [ARV] treatment regimens that are used to suppress viral load in the neurological and neurocognitive deficits that are associated with HIV-Associated Neurocognitive Disorders [HAND]. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-003.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 334305 Full Announcement-RFA-DA-22-003 -> RFA-DA-22-003-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269857 | Jan 02, 2022 | Feb 02, 2022 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00267865 | Jan 02, 2022 | Jan 24, 2022 | View |
Package 1
Mandatory forms
334305 RR_SF424_5_0-5.0.pdf
334305 PHS398_CoverPageSupplement_5_0-5.0.pdf
334305 RR_OtherProjectInfo_1_4-1.4.pdf
334305 PerformanceSite_4_0-4.0.pdf
334305 RR_KeyPersonExpanded_4_0-4.0.pdf
334305 PHS398_ResearchPlan_4_0-4.0.pdf
334305 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334305 RR_Budget_3_0-3.0.pdf
334305 RR_SubawardBudget30_3_0-3.0.pdf
334305 PHS398_ModularBudget_1_2-1.2.pdf
334305 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334305 RR_SF424_2_0-2.0.pdf
334305 PHS398_CoverPageSupplement_5_0-5.0.pdf
334305 RR_OtherProjectInfo_1_4-1.4.pdf
334305 PerformanceSite_2_0-2.0.pdf
334305 RR_KeyPersonExpanded_2_0-2.0.pdf
334305 PHS398_ResearchPlan_4_0-4.0.pdf
334305 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334305 RR_Budget_1_4-1.4.pdf
334305 RR_SubawardBudget30_1_4-1.4.pdf
334305 PHS398_ModularBudget_1_2-1.2.pdf
334305 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
